The Department of Defense is offering the MSRP Investigator-Initiated Partnership Award to attract promising investigators for translational research collaborations in addressing central problems in Multiple Sclerosis (MS) research. The grant supports partnerships of up to three independent investigators with diverse expertise, including clinicians and research scientists, from both within and outside the MS field. Projects should have clear plans for collaboration, communication, and data sharing. Applicants must demonstrate the potential short- and long-term impact of their research on improving MS patient care and quality of life. Preliminary data supporting research feasibility are required, regardless of their origin.
Opportunity ID: 254035
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-14-MSRP-IIPA |
| Funding Opportunity Title: | DoD Multiple Sclerosis Investigator-Initiated Partnership Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | CategoryExplanation |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Apr 17, 2014 |
| Last Updated Date: | Apr 17, 2014 |
| Original Closing Date for Applications: | Sep 03, 2014 |
| Current Closing Date for Applications: | Sep 03, 2014 |
| Archive Date: | Oct 03, 2014 |
| Estimated Total Program Funding: | $3,840,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The MSRP Investigator-Initiated Partnership Award (IIPA) mechanism is being offered for the first time in FY14 with the goal of attracting promising investigators and new perspectives on a research project to improve MS patient care and/or quality of life.The Investigator-Initiated Partnership Award supports the development of translational research collaborations among no more than three independent investigators (known as partners), who synergistically combine efforts to address a central problem or question in MS. The application should demonstrate each partners contribution and criticality to the project, which together bring a new perspective to MS research and create the synergy of the team. A proposed project in which one of the partners merely supplies tissue samples or access to patients does not meet the intent of this mechanism. The success of the project must depend on the contribution of unique skills and expertise of each partner. The application must include plans clearly outlining the process for interactions between all partners. The plans must include communication structure and meeting schedules, coordination of research milestones, progress updates, plans for data transfer and analysis, and sharing of results. Additionally, multi-institutional applications must provide an intellectual property plan to resolve potential intellectual and material property issues and to remove institutional barriers that might interfere with achieving the high levels of cooperation needed to ensure the successful completion of the project.Observations that drive a research project may be derived from a laboratory discovery, population-based studies, or a clinicians firsthand knowledge of patients and anecdotal data. The ultimate goal is to move an observation forward into clinical application. Important aspects of the Investigator-Initiated Partnership Award are as follows:1. Partnership: The partnership must consist of no more than three partners; the three partners include the Initiating PI and one or two Partnering PIs. The application should clearly describe each partners role, expertise, and why they are essential to the project. At least one partner must be a clinician, and at least one partner must be a research scientist. At least one partner must have experience in either MS research and/or MS patient care, and at least one partner must be from outside of the MS field. Experience in MS research is defined by a history of previous or current MS research funding and peer-reviewed MS publications. The proposed collaboration must be new in that the proposed team as a whole cannot have collaborated previously. Some, but not all, partners of the proposed collaboration may have collaborated with each other in the past. Previous collaboration is defined by a history of past or current shared research funding and/or joint peer-reviewed publication of research. Co-authorship on review papers and/or symposium summaries is not considered previous research collaboration.2. Impact: Applications should describe both the potential short- and long-term outcomes of the proposed research and their potential impact on improving MS patient care and/or quality of life.3. Preliminary Data: Preliminary data to support the feasibility of the research project and research approaches are required; however, these data do not need to come from the MS research field. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
301-682-5507 Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| The purpose of this modification is to update the help desk contact information. | Apr 17, 2014 | |
| Apr 17, 2014 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-14-MSRP-IIPA |
| Funding Opportunity Title: | DoD Multiple Sclerosis Investigator-Initiated Partnership Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | CategoryExplanation |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Apr 17, 2014 |
| Last Updated Date: | Apr 17, 2014 |
| Original Closing Date for Applications: | Sep 03, 2014 |
| Current Closing Date for Applications: | Sep 03, 2014 |
| Archive Date: | Oct 03, 2014 |
| Estimated Total Program Funding: | $3,840,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The MSRP Investigator-Initiated Partnership Award (IIPA) mechanism is being offered for the first time in FY14 with the goal of attracting promising investigators and new perspectives on a research project to improve MS patient care and/or quality of life.The Investigator-Initiated Partnership Award supports the development of translational research collaborations among no more than three independent investigators (known as partners), who synergistically combine efforts to address a central problem or question in MS. The application should demonstrate each partners contribution and criticality to the project, which together bring a new perspective to MS research and create the synergy of the team. A proposed project in which one of the partners merely supplies tissue samples or access to patients does not meet the intent of this mechanism. The success of the project must depend on the contribution of unique skills and expertise of each partner. The application must include plans clearly outlining the process for interactions between all partners. The plans must include communication structure and meeting schedules, coordination of research milestones, progress updates, plans for data transfer and analysis, and sharing of results. Additionally, multi-institutional applications must provide an intellectual property plan to resolve potential intellectual and material property issues and to remove institutional barriers that might interfere with achieving the high levels of cooperation needed to ensure the successful completion of the project.Observations that drive a research project may be derived from a laboratory discovery, population-based studies, or a clinicians firsthand knowledge of patients and anecdotal data. The ultimate goal is to move an observation forward into clinical application. Important aspects of the Investigator-Initiated Partnership Award are as follows:1. Partnership: The partnership must consist of no more than three partners; the three partners include the Initiating PI and one or two Partnering PIs. The application should clearly describe each partners role, expertise, and why they are essential to the project. At least one partner must be a clinician, and at least one partner must be a research scientist. At least one partner must have experience in either MS research and/or MS patient care, and at least one partner must be from outside of the MS field. Experience in MS research is defined by a history of previous or current MS research funding and peer-reviewed MS publications. The proposed collaboration must be new in that the proposed team as a whole cannot have collaborated previously. Some, but not all, partners of the proposed collaboration may have collaborated with each other in the past. Previous collaboration is defined by a history of past or current shared research funding and/or joint peer-reviewed publication of research. Co-authorship on review papers and/or symposium summaries is not considered previous research collaboration.2. Impact: Applications should describe both the potential short- and long-term outcomes of the proposed research and their potential impact on improving MS patient care and/or quality of life.3. Preliminary Data: Preliminary data to support the feasibility of the research project and research approaches are required; however, these data do not need to come from the MS research field. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
301-682-5507 Email:help@eBRAP.org |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-14-MSRP-IIPA |
| Funding Opportunity Title: | DoD Multiple Sclerosis Investigator-Initiated Partnership Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 17, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Sep 03, 2014 |
| Archive Date: | Oct 03, 2014 |
| Estimated Total Program Funding: | $3,840,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The MSRP Investigator-Initiated Partnership Award (IIPA) mechanism is being offered for the first time in FY14 with the goal of attracting promising investigators and new perspectives on a research project to improve MS patient care and/or quality of life. The Investigator-Initiated Partnership Award supports the development of translational research collaborations among no more than three independent investigators (known as partners), who synergistically combine efforts to address a central problem or question in MS. The application should demonstrate each partners contribution and criticality to the project, which together bring a new perspective to MS research and create the synergy of the team. A proposed project in which one of the partners merely supplies tissue samples or access to patients does not meet the intent of this mechanism. The success of the project must depend on the contribution of unique skills and expertise of each partner. The application must include plans clearly outlining the process for interactions between all partners. The plans must include communication structure and meeting schedules, coordination of research milestones, progress updates, plans for data transfer and analysis, and sharing of results. Additionally, multi-institutional applications must provide an intellectual property plan to resolve potential intellectual and material property issues and to remove institutional barriers that might interfere with achieving the high levels of cooperation needed to ensure the successful completion of the project. Observations that drive a research project may be derived from a laboratory discovery, population-based studies, or a clinicians firsthand knowledge of patients and anecdotal data. The ultimate goal is to move an observation forward into clinical application. Important aspects of the Investigator-Initiated Partnership Award are as follows: 1. Partnership: The partnership must consist of no more than three partners; the three partners include the Initiating PI and one or two Partnering PIs. The application should clearly describe each partners role, expertise, and why they are essential to the project. At least one partner must be a clinician, and at least one partner must be a research scientist. At least one partner must have experience in either MS research and/or MS patient care, and at least one partner must be from outside of the MS field. Experience in MS research is defined by a history of previous or current MS research funding and peer-reviewed MS publications. The proposed collaboration must be new in that the proposed team as a whole cannot have collaborated previously. Some, but not all, partners of the proposed collaboration may have collaborated with each other in the past. Previous collaboration is defined by a history of past or current shared research funding and/or joint peer-reviewed publication of research. Co-authorship on review papers and/or symposium summaries is not considered previous research collaboration. 2. Impact: Applications should describe both the potential short- and long-term outcomes of the proposed research and their potential impact on improving MS patient care and/or quality of life. 3. Preliminary Data: Preliminary data to support the feasibility of the research project and research approaches are required; however, these data do not need to come from the MS research field. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
301-682-5507 Email:help@cdmrp.org |
Related Documents
Folder 254035 Full Announcement-1 -> msrp_fy14 iipa pa_gg.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk 301-682-5507 Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00195430 | Apr 17, 2014 | Sep 03, 2014 | View |
Package 1
Mandatory forms
254035 RR_SF424_2_0-2.0.pdf
254035 RR_Budget_1_3-1.3.pdf
254035 PerformanceSite_2_0-2.0.pdf
Optional forms
254035 RR_KeyPersonExpanded_2_0-2.0.pdf
254035 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
